Eflapegrastim

Unassigned

New Medicines

Rolontis · Chemotherapy-induced neutopenia

Information

Rolontis
New molecular entity
Spectrum
Spectrum

Development and Regulatory status

None
None
Filing withdrawn

Category

Long‐acting granulocyte colony‐stimulating factor (G‐CSF) analogue, injected every 3 weeks.
Neutropenia is associated with cancer chemotherapy. Moderate neutropenia is defined as neutrophil count of 0.5-1.0 x 109/L, severe neutropenia is a count of <0.5 x 109/L.
Chemotherapy-induced neutopenia
Subcutaneous injection